Pictet-Biotech R/ LU0255977539 /
NAV1/26/2023 | Chg.+6.4100 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
646.6200EUR | +1.00% | reinvestment | Equity Worldwide | Pictet AM (EU) ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 | - | - | - | - | - | - | 0.84 | 1.85 | 2.95 | 10.42 | -3.06 | 1.02 | - |
2007 | 3.34 | -4.25 | -1.84 | 5.32 | 3.29 | -3.91 | -1.11 | 6.27 | 2.00 | 3.22 | -3.15 | -4.98 | +3.38% |
2008 | -4.41 | -5.17 | -3.32 | 4.55 | 2.67 | -2.39 | 16.34 | 1.66 | -2.26 | -5.40 | -10.37 | -0.59 | -10.51% |
2009 | 10.45 | -9.17 | -0.84 | -7.23 | -4.55 | 8.23 | 4.46 | -3.91 | 2.87 | -12.00 | 2.24 | 7.82 | -4.49% |
2010 | 4.77 | 1.10 | 6.04 | 1.89 | -7.76 | -4.93 | -0.63 | -0.34 | 3.14 | 1.13 | 3.98 | 6.36 | +14.65% |
2011 | -3.18 | 0.49 | 1.10 | 0.46 | 2.35 | -3.26 | -1.97 | -12.23 | 1.09 | 3.61 | 3.98 | 3.98 | -4.66% |
2012 | 8.26 | -2.51 | 5.47 | 2.64 | 5.95 | 5.64 | 4.66 | -2.37 | 2.46 | -8.50 | 4.02 | -2.98 | +23.63% |
2013 | 4.30 | 4.32 | 9.39 | 3.72 | 4.48 | -4.57 | 9.70 | 0.52 | 5.77 | -5.45 | 7.22 | 0.74 | +46.60% |
2014 | 11.51 | 4.53 | -10.04 | -7.66 | 3.14 | 7.40 | -0.09 | 9.68 | 2.42 | 9.08 | 3.04 | 2.85 | +39.17% |
2015 | 14.06 | 5.94 | 6.10 | -8.93 | 13.48 | 0.15 | 3.94 | -11.11 | -9.99 | 5.98 | 7.66 | -2.79 | +22.41% |
2016 | -21.97 | -6.72 | -0.69 | 6.42 | 3.23 | -7.60 | 11.53 | -4.22 | 0.95 | -8.58 | 10.84 | -3.04 | -22.26% |
2017 | 4.13 | 8.93 | -1.57 | 0.03 | -7.35 | 7.78 | -0.68 | 3.86 | 0.45 | -5.41 | -2.55 | 1.83 | +8.48% |
2018 | 2.84 | -3.22 | -3.05 | -1.91 | 7.81 | 1.31 | 3.44 | 4.16 | -1.05 | -11.71 | 2.11 | -10.62 | -11.20% |
2019 | 14.34 | 5.16 | 0.14 | -3.63 | -3.50 | 6.38 | 2.49 | -4.83 | -4.49 | 5.70 | 14.73 | -1.57 | +32.45% |
2020 | -2.90 | -1.58 | -4.11 | 18.44 | 2.82 | 1.12 | -6.33 | -0.63 | 7.96 | -3.31 | 4.25 | 1.65 | +16.18% |
2021 | 4.74 | -2.88 | -0.86 | -1.19 | -5.38 | 6.81 | -1.89 | 5.03 | -1.27 | -2.52 | -4.29 | 2.77 | -1.76% |
2022 | -17.46 | -2.71 | 4.87 | -5.12 | -5.63 | 7.70 | 8.65 | 6.38 | 0.24 | 0.99 | -0.55 | -5.63 | -10.84% |
2023 | 1.54 | - | - | - | - | - | - | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 21.21% | 24.02% | 30.24% | 27.07% | 25.23% |
Sharpe ratio | 1.18 | 0.15 | 0.28 | -0.03 | 0.01 |
Best month | +1.54% | +8.65% | +8.65% | +18.44% | +18.44% |
Worst month | -5.63% | -5.63% | -17.46% | -17.46% | -17.46% |
Maximum loss | -3.93% | -12.26% | -20.40% | -37.96% | -37.96% |
Outperformance | +2.44% | - | +0.28% | -2.80% | -20.41% |
All quotes in EUR
Tranches
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
Pictet-Biotech I | reinvestment | 890.5500 | +12.56% | +10.51% | |
Pictet-Biotech HI | reinvestment | 543.6600 | +4.97% | +2.50% | |
Pictet-Biotech I dy | paying dividend | 783.6100 | +18.50% | +15.23% | |
Pictet-Biotech Z | reinvestment | 1,078.7900 | +9.65% | +12.39% | |
Pictet-Biotech I | reinvestment | 968.8700 | +8.58% | +9.11% | |
Pictet-Biotech P dy | paying dividend | 813.5100 | +7.61% | +6.27% | |
Pictet-Biotech R | reinvestment | 703.9200 | +6.86% | +4.06% | |
Pictet-Biotech R | reinvestment | 646.6200 | +10.78% | +5.35% | |
Pictet-Biotech P dy | paying dividend | 657.5600 | +17.45% | +12.16% | |
Pictet-Biotech HP | reinvestment | 620.7600 | +3.83% | -0.81% | |
Pictet-Biotech HP | reinvestment | 511.0700 | +4.03% | -0.23% | |
Pictet-Biotech P | reinvestment | 747.6900 | +11.55% | +7.57% | |
Pictet-Biotech HR | reinvestment | 441.9700 | +3.30% | -2.30% | |
Pictet-Biotech P | reinvestment | 813.8100 | +7.61% | +6.27% |
Performance
YTD | +1.54% | ||
---|---|---|---|
6 Months | +3.01% | ||
1 Year | +10.78% | ||
3 Years | +5.35% | ||
5 Years | +14.64% | ||
10 Years | +142.87% | ||
Since start | +261.46% | ||
Year | |||
2022 | -10.84% | ||
2021 | -1.76% | ||
2020 | +16.18% | ||
2019 | +32.45% | ||
2018 | -11.20% | ||
2017 | +8.48% | ||
2016 | -22.26% | ||
2015 | +22.41% | ||
2014 | +39.17% |